Inspire Advisors, LLC Regenxbio Inc. Transaction History

Inspire Advisors, LLC

  • $686 Million
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 26, 2023
SELL
$16.46 - $19.99 $376,061 - $456,711
-22,847 Reduced 50.27%
22,606 $372,000
Q2 2023

Jul 31, 2023
BUY
$17.23 - $21.71 $92,421 - $116,452
5,364 Added 13.38%
45,453 $908,000
Q1 2023

Apr 24, 2023
BUY
$18.08 - $24.55 $724,809 - $984,184
40,089 New
40,089 $758,000

Others Institutions Holding RGNX

# of Institutions
193
Shares Held
42M
Call Options Held
80.6K
Put Options Held
55.2K
View Full List

About REGENXBIO Inc.

RGNX Quotes by TradingView
  • Ticker RGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,230,000
  • Market Cap $458M
  • Description
  • REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...
More about RGNX
Track This Portfolio

Track Inspire Advisors, LLC Portfolio

Follow Inspire Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Inspire Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Inspire Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email